The Newest Cathinone Derivatives As Designer Drugs: an Analytical and Toxicological Review

Total Page:16

File Type:pdf, Size:1020Kb

The Newest Cathinone Derivatives As Designer Drugs: an Analytical and Toxicological Review Forensic Toxicol DOI 10.1007/s11419-017-0385-6 REVIEW ARTICLE The newest cathinone derivatives as designer drugs: an analytical and toxicological review 1,3 3 2 1 Milena Majchrzak • Rafał Celin´ski • Piotr Kus´ • Teresa Kowalska • Mieczysław Sajewicz1 Received: 30 July 2017 / Accepted: 22 August 2017 Ó The Author(s) 2017. This article is an open access publication Abstract Conclusions To our knowledge, this is the most current Purpose Currently, among new psychoactive substances, review presenting new synthetic cathinones. Political cathinone derivatives constitute the biggest group, which authorities should take measures to implement and enforce are mainly classified into N-alkylated, 3,4-methylenedioxy- generic scheduling (comprehensive system) laws to control N-alkylated, N-pyrrolidinyl, and 3,4-methylenedioxy-N- the diversely modified synthetic cathinones. Supplement- pyrrolidinyl derivatives. These derivatives are actively ing the existing databases with new findings can greatly being subjected to minor modifications at the alkyl chains facilitate the efforts of forensic toxicologists. or the aromatic ring to create new synthetic cathinones with the goal of circumventing laws. In this review, the new Keywords New synthetic cathinones Á Designer drugs Á synthetic cathinones that have appeared on the illegal drug NPS Á LC–MS Á GC–MS Á NMR market during the period 2014–2017 are highlighted, and their characterization by gas chromatography–mass spec- trometry and liquid chromatography–tandem mass spec- Introduction trometry is presented. Methods Various key words were used to conduct an Cathinone is one of the biologically active alkaloids found extensive literature search across a number of databases, in the khat shrub (Catha edulis). Due to its psychoactive specifically for synthetic cathinones that emerged between properties, khat has been known and utilized for ages by 2014 and 2017. the inhabitants of East Africa and the northeastern parts of Results More than 30 new cathinone derivatives were Arabian Peninsula. In many regions, chewing of freshly discovered. The preexisting parental compounds for the collected khat leaves (thus liberating cathinone, which new derivatives are also referenced, and their mass spectral affects the central nervous system) is considered a matter data are compiled in a table to facilitate their identification of culture and local tradition [1–4]. Because of their by forensic toxicologists. structural similarity to amphetamine, cathinone and its analogs are often denoted as ‘‘natural amphetamines’’, and the only structural difference between amphetamine and & Milena Majchrzak cathinone is the presence of a carbonyl group in the a- [email protected] position of cathinone’s side chain. Similar to amphetamine, 1 cathinone and its analogs are characterized by stimulating, Department of General Chemistry and Chromatography, euphoric, and empathogenic properties [1, 2, 4–6]. Institute of Chemistry, University of Silesia, 9 Szkolna Street, 40-006 Katowice, Poland Due to their effects on the central nervous system, the first synthetic cathinone derivatives were synthesized for 2 Department of Organic Synthesis, Institute of Chemistry, University of Silesia, 9 Szkolna Street, 40-006 Katowice, medicinal purposes in the early twentieth century, but Poland they began attracting wider attention around the year 3 Toxicology Laboratory ToxLab, 6 Kossutha Street, 2000. At that time, synthetic cathinones were included in 40-844 Katowice, Poland a broader group of psychoactive compounds denoted as 123 Forensic Toxicol ‘‘legal drugs’’ or ‘‘designer drugs’’ [5–8]. Over the course Chemistry of the past 15 years, cathinone derivatives have gradually become available from so-called smart shops, through the The structures of the first synthetic cathinones have been Internet, and from drug paraphernalia stores advertising, continuously modified to this day, so that each year several for example, ‘‘funny items’’ or ‘‘aromas’’ [9–11]. Syn- new derivatives emerge on an illegal designer drug market. thetic cathinones are most often sold as white or colored Given these circumstances, the identification of these crystalline powders, and rather rarely as tablets or cap- compounds and implementation of a drug library with new sules. In the past, products containing active ingredients structures and their physicochemical and pharmacological from the cathinone group were advertised as ‘‘plant characteristics become an analytical challenge equally nutrients’’, ‘‘bath salts’’, or ‘‘research chemicals’’. Nowa- important for chemists and toxicologists. days, the same substances are frequently labeled with The structures of all synthetic cathinones are derived such names as ‘‘conquerors of leeches’’, ‘‘driver’s from that of natural cathinone, and they can be considered charms’’, ‘‘additives to sand’’, and ‘‘bidet refreshers’’. to be phenylalkylamine derivatives, which structurally Quite often, these preparations contain a combination of resemble the molecule of amphetamine with a carbonyl two or more cathinone derivatives, along with other group in the a-position of the side chain adjacent to the type(s) of new psychoactive substances, caffeine, lido- aromatic ring. Nowadays, cathinone derivatives can be caine, or benzocaine [12]. divided into four groups. Group 1 includes N-alkyl com- pounds or those with an alkyl or halogen substituent at any possible position of the aromatic ring (Table 1). The Background majority of the first synthetic cathinones fall into this group, and they include ethcathinone, ephedrone, mephe- Synthetic cathinones first made their appearance in the drone, flephedrone, buphedrone, and pentedrone. Group 2 third decade of the twentieth century, solely for medicinal includes methylenedioxy-substituted compounds with purposes (to treat patients with parkinsonism, obesity, or substituents at any given position of aromatic ring, such as depression), but at the beginning of the twenty-first cen- methylone, pentylone, and butylone. In terms of their tury, they began to be consumed recreationally as sub- structure and pharmacological effect, these compounds are stitutes for controlled drugs. After the year 2000, two quite similar to 3,4-methylenedioxymethamphetamine pioneering representatives from this group emerged on the (MDMA) (Table 2). Cathinones from group 3 (examples illegal market, namely CAT (methcathinone) and 4-MMC given in Table 3) are analogs of natural cathinone with an (mephedrone, 4-methylmethcathinone), which were fol- N-pyrrolidinyl substituent, and these compounds are cur- lowed by methylone (3,4-methylenedioxy-N-methylcathi- rently the most frequently encountered in the designer drug none) and MDPV (3,4-methylenedioxypyrovalerone’’) market. Compounds which include both methylenedioxyl [6, 12, 13]. Immediately after their disclosure, the full and N-pyrrolidinyl substituents belong to group 4 synthetic chemical and psychoactive characteristics of these com- cathinones (Table 4)[6]. pounds were realized; as a consequence, in many coun- tries, they became illegal, and clandestine synthetic chemists began modifying their structures to obtain new Mechanisms of action and metabolism analogs. In that way, new cathinones were synthesized as substitute drugs, including butylone, ethylone, buphe- In vitro experiments have shown that synthetic cathinones drone, and an analog of the latter, pentedrone, which was easily penetrate the blood-brain barrier (BBB) [13]. soon replaced by its constitutional isomer, 4-MEC (4- Cathinone and its derivatives (denoted as b-keto-am- methyl-N-ethylcathinone). About the same time, the phetamines) exert a stimulating and sympathomimetic chemical structure of mephedrone was modified by effects on the central nervous system due to an increased introducing new substituents to the aromatic ring; in concentrations of catecholamines in the inter-synapse 2009, 4-FMC (flephedrone, 4-fluoromethcathinone) and spaces, and their effects are generally much stronger than its positional isomer 3-FMC (3-fluoromethcathinone) that of amphetamine itself [2, 14–21]. Similar to amphe- appeared. Along with pentedrone, a second-generation tamine, cathinones exist as two stereoisomeric forms, and synthetic cathinone, a-PVP (a-pyrrolidinopentiophenone), each is characterized by different potency [6]. The mech- appeared, which belongs to the same group [5, 6, 12]. anism of action of synthetic cathinones involves the inhi- bition of monoamine transporters such as dopamine transporter (DAT), noradrenaline transporter (NAT), and serotonin transporter (SERT). Depending on the derivative, 123 Forensic Toxicol Table 1 Chemical names, common names, chemical structures, and molecular weights of N-alkylated cathinone derivatives (group 1) Chemical name Common name Chemical structure Molecular weight [Da] [2-(N-Methylamino)-butan-1-onyl]- Buphedrone, a-methylaminobutyrophenone 177.24 benzene [2-(N-Ethylamino)-propan-1- onyl]- Ethcathinone, ETCAT, N-ethylcathinone 177.24 benzene [2-(N-Methylamino)-propan-1-onyl]- Ephedrone, methcathinone, CAT, a- 163.22 benzene methylaminopropiophenone 1-[2-(N-Methylamino)-propan-1- onyl]-4- Flephedrone, 4-FMC, 4-fluoromethcathinone 181.22 fluorobenzene 1-[2-(N-Methylamino)-propan-1- onyl]-4- Mephedrone, 4-MMC, 177.24 methylbenzene 4-methylmethcathinone [2-(N-Methylamino)-pentan-1- onyl]- Pentedrone, a-methylaminovalerophenone 191.27 benzene 1-[2-(N-Methylamino)-propan-1- onyl]- 3,4-DMMC, 3,4-dimethylmethcathinone 191.27 3,4-dimethylbenzene and more precisely, on its chemical structure,
Recommended publications
  • Recommended Methods for the Identification and Analysis of Synthetic Cathinones in Seized Materialsd
    Recommended methods for the Identification and Analysis of Synthetic Cathinones in Seized Materials (Revised and updated) MANUAL FOR USE BY NATIONAL DRUG ANALYSIS LABORATORIES Photo credits:UNODC Photo Library; UNODC/Ioulia Kondratovitch; Alessandro Scotti. Laboratory and Scientific Section UNITED NATIONS OFFICE ON DRUGS AND CRIME Vienna Recommended Methods for the Identification and Analysis of Synthetic Cathinones in Seized Materials (Revised and updated) MANUAL FOR USE BY NATIONAL DRUG ANALYSIS LABORATORIES UNITED NATIONS Vienna, 2020 Note Operating and experimental conditions are reproduced from the original reference materials, including unpublished methods, validated and used in selected national laboratories as per the list of references. A number of alternative conditions and substitution of named commercial products may provide comparable results in many cases. However, any modification has to be validated before it is integrated into laboratory routines. ST/NAR/49/REV.1 Original language: English © United Nations, March 2020. All rights reserved, worldwide. The designations employed and the presentation of material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the United Nations concerning the legal status of any country, territory, city or area, or of its authorities, or concerning the delimitation of its frontiers or boundaries. Mention of names of firms and commercial products does not imply the endorse- ment of the United Nations. This publication has not been formally edited. Publishing production: English, Publishing and Library Section, United Nations Office at Vienna. Acknowledgements The Laboratory and Scientific Section of the UNODC (LSS, headed by Dr. Justice Tettey) wishes to express its appreciation and thanks to Dr.
    [Show full text]
  • 2015-02 Toxicology Rapid Testing Panel
    SOUTH CAROLINA LAW ENFORCEMENT DIVISION NIKKI R. HALEY MARK A. KEEL Governor Chief FORENSIC SERVICES LABORATORY CUSTOMER NOTICE 2015-02 REGARDING TOXICOLOGY RAPID TESTING PANEL August 12, 2015 This notice is to inform the Coroners of South Carolina of a new testing panel available through the SLED Toxicology Department. On Monday, August 17th, the Toxicology Department will begin offering both a Rapid Testing Panel in addition to the already available Expanded Testing Panel. This Rapid Testing Panel is to be utilized in cases where the Expanded Testing Panel is not warranted, specifically where a cause of death has already been established. The Rapid Testing Panel will consist of volatiles analysis, to include, ethanol, acetone, isopropanol and methanol, drug screens, and drug confirmation/quantitation of positive screens. The cases assigned to the Rapid Testing Panel will have an expedited turnaround time. Targeted turn around times will be two weeks for negative cases and six weeks or less for positive cases. While every effort will be made to adhere to these time frames, additional time may be required on occasion due to the nature of postmortem samples. Submitters will be notified if there is a problem with a particular sample. Please see attachment regarding specifically which substances are covered by the Rapid Testing Panel and the Expanded Testing Panel. As always, a detailed case history and list of drugs suspected is appreciated. Rapid Panel and Expanded Panel will be choices available in iLAB. Please contact Lt. Dustin Smith (803-896-7385) with additional questions. ALI-359-T An Accredited Law Enforcement Agency P.O.
    [Show full text]
  • 3,4-Methylenedioxymethcathinone (Methylone) [“Bath Salt,” Bk-MDMA, MDMC, MDMCAT, “Explosion,” “Ease,” “Molly”] December 2019
    Drug Enforcement Administration Diversion Control Division Drug & Chemical Evaluation Section 3,4-Methylenedioxymethcathinone (Methylone) [“Bath salt,” bk-MDMA, MDMC, MDMCAT, “Explosion,” “Ease,” “Molly”] December 2019 Introduction: discriminate DOM from saline. 3,4-Methylenedioxymethcathinone (methylone) is a Because of the structural and pharmacological similarities designer drug of the phenethylamine class. Methylone is a between methylone and MDMA, the psychoactive effects, adverse synthetic cathinone with substantial chemical, structural, and health risks, and signs of intoxication resulting from methylone pharmacological similarities to 3,4-methylenedioxymeth- abuse are likely to be similar to those of MDMA. Several chat amphetamine (MDMA, ecstasy). Animal studies indicate that rooms discussed pleasant and positive effects of methylone when methylone has MDMA-like and (+)-amphetamine-like used for recreational purpose. behavioral effects. When combined with mephedrone, a controlled schedule I substance, the combination is called User Population: “bubbles.” Other names are given in the above title. Methylone, like other synthetic cathinones, is a recreational drug that emerged on the United States’ illicit drug market in 2009. It is perceived as being a ‘legal’ alternative to drugs of Licit Uses: Methylone is not approved for medical use in the United abuse like MDMA, methamphetamine, and cocaine. Evidence States. indicates that youths and young adults are the primary users of synthetic cathinone substances which include methylone. However, older adults also have been identified as users of these Chemistry: substances. O H O N CH3 Illicit Distribution: CH O 3 Law enforcement has encountered methylone in the United States as well as in several countries including the Netherlands, Methylone United Kingdom, Japan, and Sweden.
    [Show full text]
  • (19) United States (12) Patent Application Publication (10) Pub
    US 20130289061A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2013/0289061 A1 Bhide et al. (43) Pub. Date: Oct. 31, 2013 (54) METHODS AND COMPOSITIONS TO Publication Classi?cation PREVENT ADDICTION (51) Int. Cl. (71) Applicant: The General Hospital Corporation, A61K 31/485 (2006-01) Boston’ MA (Us) A61K 31/4458 (2006.01) (52) U.S. Cl. (72) Inventors: Pradeep G. Bhide; Peabody, MA (US); CPC """"" " A61K31/485 (201301); ‘4161223011? Jmm‘“ Zhu’ Ansm’ MA. (Us); USPC ......... .. 514/282; 514/317; 514/654; 514/618; Thomas J. Spencer; Carhsle; MA (US); 514/279 Joseph Biederman; Brookline; MA (Us) (57) ABSTRACT Disclosed herein is a method of reducing or preventing the development of aversion to a CNS stimulant in a subject (21) App1_ NO_; 13/924,815 comprising; administering a therapeutic amount of the neu rological stimulant and administering an antagonist of the kappa opioid receptor; to thereby reduce or prevent the devel - . opment of aversion to the CNS stimulant in the subject. Also (22) Flled' Jun‘ 24’ 2013 disclosed is a method of reducing or preventing the develop ment of addiction to a CNS stimulant in a subj ect; comprising; _ _ administering the CNS stimulant and administering a mu Related U‘s‘ Apphcatlon Data opioid receptor antagonist to thereby reduce or prevent the (63) Continuation of application NO 13/389,959, ?led on development of addiction to the CNS stimulant in the subject. Apt 27’ 2012’ ?led as application NO_ PCT/US2010/ Also disclosed are pharmaceutical compositions comprising 045486 on Aug' 13 2010' a central nervous system stimulant and an opioid receptor ’ antagonist.
    [Show full text]
  • 4-Methylethcathinone (4-MEC)
    4‐Methylethcathinone (4‐MEC) Critical Review Report Agenda item 4.15 (R/S)‐ 2‐(Ethylamino)‐1‐(4‐methylphenyl) propan‐1‐one (4‐methyl‐N‐ethylcathinone, 4‐MEC) Expert Committee on Drug Dependence Thirty‐sixth Meeting Geneva, 16‐20 June 2014 36th ECDD (2014) Agenda item 4.15 4‐Methylethcathinone (4‐MEC) Page 2 of 20 36th ECDD (2014) Agenda item 4.15 4‐Methylethcathinone (4‐MEC) Acknowledgements This report has been drafted under the responsibility of the WHO Secretariat, Essential Medicines and Health Products, Policy Access and Rational Use Unit. The WHO Secretariat would like to thank the following people for their contribution in producing this critical review report: Dr Simon Brandt, United Kingdom (literature review and drafting), Dr Caroline Bodenschatz, Switzerland (editing) and Mr David Beran, Switzerland (questionnaire report drafting). Page 3 of 20 36th ECDD (2014) Agenda item 4.15 4‐Methylethcathinone (4‐MEC) Page 4 of 20 36th ECDD (2014) Agenda item 4.15 4‐Methylethcathinone (4‐MEC) Contents Summary.................................................................................................................................................................... 7 1. Substance identification ............................................................................................................................... 8 A. International Nonproprietary Name (INN) ......................................................................................... 8 B. Chemical Abstract Service (CAS) Registry Number ..........................................................................
    [Show full text]
  • Structure-Cytotoxicity Relationship Profile of 13 Synthetic Cathinones In
    Neurotoxicology 75 (2019) 158–173 Contents lists available at ScienceDirect Neurotoxicology journal homepage: www.elsevier.com/locate/neuro Structure-cytotoxicity relationship profile of 13 synthetic cathinones in differentiated human SH-SY5Y neuronal cells T ⁎ Jorge Soaresa, , Vera Marisa Costaa, Helena Gasparb,c, Susana Santosd,e, Maria de Lourdes Bastosa, ⁎ Félix Carvalhoa, João Paulo Capelaa,f, a UCIBIO, REQUIMTE (Rede de Química e Tecnologia), Laboratório de Toxicologia, Departamento de Ciências Biológicas, Faculdade de Farmácia, Universidade do Porto, Portugal b BioISI – Instituto de Biossistemas e Ciências Integrativas, Faculdade de Ciências, Universidade de Lisboa, Portugal c MARE - Centro de Ciências do Mar e do Ambiente, Escola Superior de Turismo e Tecnologia do Mar, Instituto Politécnico de Leiria, Portugal d Centro de Química e Bioquímica (CQB), Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade de Lisboa, Portugal e Centro de Química Estrutural, Faculdade de Ciências, Universidade de Lisboa, Portugal f FP-ENAS (Unidade de Investigação UFP em Energia, Ambiente e Saúde), CEBIMED (Centro de Estudos em Biomedicina), Faculdade de Ciências da Saúde, Universidade Fernando Pessoa, Portugal ARTICLE INFO ABSTRACT Keywords: Synthetic cathinones also known as β-keto amphetamines are a new group of recreational designer drugs. We Synthetic cathinones aimed to evaluate the cytotoxic potential of thirteen cathinones lacking the methylenedioxy ring and establish a Classical amphetamines putative structure-toxicity profile using differentiated SH-SY5Y cells, as well as to compare their toxicity to that Cytotoxicity of amphetamine (AMPH) and methamphetamine (METH). Cytotoxicity assays [mitochondrial 3-(4,5-dimethyl-2- SH-SY5Y cells thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) reduction and lysosomal neutral red (NR) uptake] per- Structure-toxicity relationship formed after a 24-h or a 48-h exposure revealed for all tested drugs a concentration-dependent toxicity.
    [Show full text]
  • Immediate Action New Tests and Test Updates
    Effective Date: Monday, August 26, 2013 New Tests and Test Updates Immediate Action In our continuing effort to provide you with the highest quality toxicology laboratory services available, we have compiled important changes regarding a number of tests we perform. Listed below are the types of changes that may be included in this notification, effective Monday, August 26, 2013 New Tests - Tests recently added to the NMS Labs test menu. New Tests are effective immediately. Test Changes - Tests that have had changes to the method/ CPT code, units of measurement, scope of analysis, reference comments, or specimen requirements. Discontinued Tests - Tests being discontinued with alternate testing suggestions. Please use this information to update your computer systems/records. These changes are important to ensure standardization of our mutual laboratory databases. If you have any questions about the information contained in this notification, please call our Client Support Department at (866) 522-2206. Thank you for your continued support of NMS Labs and your assistance in implementing these changes. The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. NMS Labs does not assume responsibility for billing errors due to reliance on the CPT Codes listed in this document. NMS LABS 3701 Welsh Road Willow Grove, PA 19090 www.NMSLabs.com Page 1 of 76 Effective Date: Monday, August 26, 2013 New Tests and Test Updates Test Test Name New Test Method / Specimen Stability Scope Units Reference Discontinue
    [Show full text]
  • 10.30.19 Didactic
    STIMULANTS PART II Michael H. Baumann, Ph.D. Designer Drug Research Unit (DDRU), Intramural Research Program, NIDA, NIH Baltimore, MD 21224 Chronology of Stimulant Misuse 1. 2000s: Methamphetamine 2. 2010s: Bath Salts 3. Summary 2 Topics Covered for Each Substance Chemistry Formulations and Methods of Use Pharmacokinetics and Metabolism Desired and Adverse Effects Chronic and Withdrawal Effects Neurobiology Treatments 2000s: Methamphetamine Methamphetamine, a synthetic stimulant 5 Formulations and Methods of Use Methamphetamine (i.e., Ice or Crystal) Smoking using pipes Methamphetamine HCl Intravenous injection of solutions using needle and syringe Intranasal snorting of crystals Pharmacokinetics and Metabolism Pharmacokinetics Smoked and intravenous drugs reach brain within seconds Intranasal drug reaches brain within minutes Much longer half-life than cocaine Metabolism N-demethylation to form amphetamine (bioactive) Hydroxylation to form inactive metabolites Desired Effects Enhanced Mood and Euphoria Increased Attention and Alertness Decreased Need for Sleep Appetite Suppression Sexual Arousal Adverse Effects Psychosis Arrhythmias, Palpitations, Heart Attack Hypertension, Stroke Hyperthermia, Rhabdomyolysis Multisystem Organ Failure 11 www.facesofmeth.us. “METH Mouth” 12 Molecular Sites of Action SLC6 Monoamine Transporters Dopamine transporter (DAT) Norepinephrine transporter (NET) 5-HT transporter (SERT) Other sites Vesicular Monoamine Transporter 2 (VMAT2) Trace amine-associated receptors (TAAR1)
    [Show full text]
  • The Enantioselective-Controlled Delivery of Propranolol by Cellulose
    The Enantioselective-Controlled Delivery of Propranolol by Cellulose Membrane Grafted with Molecularly Imprinted Polymer Chatchada Bodhibukkana A Thesis Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy in Pharmaceutical Sciences Prince of Songkla University 2008 i Copyright of Prince of Songkla University Thesis Title The Enantioselective-Controlled Delivery of Propranolol by Cellulose Membrane Grafted with Molecularly Imprinted Polymer Author Miss Chatchada Bodhibukkana Major program Pharmaceutical Sciences Major Advisor Examining Committee ………………………………………… ………………………………Chairperson (Assoc. Prof. Dr. Roongnapa Srichana) (Assoc. Prof. Dr. Ruedeekorn Wiwattanapatapee) ………………………………Committee Co-advisor (Assoc. Prof. Dr. Varaporn Junyaprasert ) ………………………………………… ………………………………Committee (Assoc. Prof. Dr. Teerapol Srichana) (Assoc. Prof. Dr. Roongnapa Srichana) ………………………………………… ………………………………Committee (Prof. Gary P. Martin) (Assoc. Prof. Dr. Teerapol Srichana) The Graduate School, Prince of Songkla University, has approved this thesis as partial fulfillment of the requirements for the Doctor of Philosophy Degree in Pharmaceutical Sciences …………………………………………… (Assoc. Prof. Dr. Krerkchai Thongnoo) Dean of Graduate School ii propranolol !" #$ %& '(")* %&% **+, - )!,!. */*- 0 1,!2 ( 2550 ! 26 7 %8%),(9-+:%&;*,< + (composite membrane) #$ ; :%%* %&% **+, (Molecularly imprinted polymer, MIP) *& !" L* %&L* ; ; S-enantiomer ; racemic propranolol + ,: N68 +%& +N$'O !,& %&$*- #$ ")
    [Show full text]
  • Issue 11 - Jan - Mar 2017 Collection Andtestingofsubstancesand,Most WEDINOS Quarterly Newsletter
    Collecting, Testing, Informing wedinos.org BULLETIN WEDINOS Quarterly Newsletter Issue 11 - Jan Mar 2017 The WEDINOS project has been designed for the collection and testing of substances and, most importantly, dissemination via www.wedinos.org of pragmatic evidence based harm reduction WEDINOS information for users. WEDINOS aims to go beyond identification of novel substances, to address the Headlines harms associated with use of New Psychoactive Substances (NPS), new combinations of established drugs and NPS and Steroids & Image Enhancing Drugs (SIEDs). TOTAL number of samles received by WEDINOS October 201 to March 2017 This uarter ,2 (January 2017 to March 2017) Samles received 396 Samles received ,0 Samles 221 analysed Samles analysed 89 86 Samles Samles 7 ending 345 ending Substances Substances identified in identified in either either 89 combination or combination Samles isolation or isolation reected 1 FINDINGS… WHERE... Samples were submitted from six of the Breakdown of sample submissions by Health Board areas seven Welsh Health Boards. No samples 49 samples were received from England, were received form Powys Teaching A - Betsi Cadwaladr University Health five from Scotland and one from outside Health Board. Board – 20 samples. the United Kingdom. B - Powys Teaching Health Board – 0 samples. WEDINOS does not analyse samples C - Aneurin Bevan University Health A received from outside of the United Board – 62 samples. Kingdom. D - Cwm Taf University Health Board – 10 samples. In relation to Welsh Health Board areas, E - Cardiff & Vale University Health Board the highest proportion of samples came – 44 samples. from Aneurin Bevan University Health F - Abertawe Bro Morgannwg University B Board, 62 samples were received and Health Board – 21 samples.
    [Show full text]
  • TURKEY MINISTRY of INTERIOR TURKISH NATIONAL POLICE Anti-Smuggling and Organized Crime Department
    REPUBLIC OF TURKEY MINISTRY OF INTERIOR TURKISH NATIONAL POLICE Anti-Smuggling and Organized Crime Department 2014 NATIONAL REPORT (2013 data) TO THE EMCDDA by the Reitox National Focal Point TURKEY New Development, Trends and in-depth information on selected issues TURKISH MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION (TUBİM) REITOX 1 TABLE OF CONTENTS TABLE OF CONTENTS ........................................................................................................... 2 TURKISH NATIONAL FOCAL POINT STAFF PREPARING THE REPORT ........................... 7 DATA PROVIDING AGENCIES AND AGENCY REPRESENTATIVES ................................... 8 PREFACE .............................................................................................................................. 11 ABBREVIATIONS .................................................................................................................. 13 SUMMARY ............................................................................................................................. 15 NEW DEVELOPMENTS AND TRENDS ................................................................................ 29 SECTION 1 ............................................................................................................................ 29 DRUG POLICY: LAWS, STRATEGIES, AND ECONOMIC ANALYSES ............................... 29 1.1. Introduction ................................................................................................................ 29 1.2. Legal Framework
    [Show full text]
  • Positive Allosteric Modulators (Pams) in Mouse Models of Overt Cannabimimetic Activity, Subjective Drug Effects, and Neuropathic Pain
    Virginia Commonwealth University VCU Scholars Compass Theses and Dissertations Graduate School 2021 Investigating Cannabinoid Type-1 Receptor (CB1R) Positive Allosteric Modulators (PAMs) in Mouse Models of Overt Cannabimimetic Activity, Subjective Drug Effects, and Neuropathic Pain Jayden Elmer Virginia Commonwealth University Follow this and additional works at: https://scholarscompass.vcu.edu/etd Part of the Behavioral Neurobiology Commons, Behavior and Behavior Mechanisms Commons, Medicinal and Pharmaceutical Chemistry Commons, Nervous System Diseases Commons, and the Pharmacology Commons © The Author Downloaded from https://scholarscompass.vcu.edu/etd/6777 This Thesis is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact [email protected]. 2021 Investigating Cannabinoid Type-1 Receptor (CB1R) Positive Allosteric Modulators (PAMs) in Mouse Models of Overt Cannabimimetic Activity, Subjective Drug Effects and Neuropathic Pain Jayden A. Elmer Investigating Cannabinoid Type-1 Receptor (CB1R) Positive Allosteric Modulators (PAMs) in Mouse Models of Overt Cannabimimetic Activity, Subjective Drug Effects and Neuropathic Pain A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science at Virginia Commonwealth University By Jayden Aric Elmer Bachelor of Science, University of Virginia, 2018 Director: Dr. Aron Lichtman, Professor, Department of Pharmacology & Toxicology; Associate Dean of Research and Graduate Studies, School of Pharmacy Virginia Commonwealth University Richmond, Virginia July 2021 Acknowledgements I would first like to extend my gratitude towards the CERT program at VCU. The CERT program opened the doors for me to get involved in graduate research.
    [Show full text]